
Featured Research: Human-Derived Tumor-On-Chip Models Are Shaping the Future of Precision Breast Cancer Care
A recent peer-reviewed publication explores how human-derived Tumor-on-Chip technology can improve our understanding of breast cancer heterogeneity and support more personalized treatment strategies. The study also features contributions from Minoo Shahani, CEO of Sein Medical.
Read more






